文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

自闭症谱系障碍精神药理学的几十年进展。

Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder.

机构信息

Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 4002, Cincinnati, OH, 45229, USA.

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati School of Medicine, Cincinnati, USA.

出版信息

J Autism Dev Disord. 2021 Dec;51(12):4370-4394. doi: 10.1007/s10803-021-05237-9. Epub 2021 Sep 7.


DOI:10.1007/s10803-021-05237-9
PMID:34491511
Abstract

Recent decades have been marked by a wave drug treatment research in autism spectrum disorder (ASD). This work has resulted in improved ability to treat commonly occurring behavioral challenges associated with ASD including most prominently irritability marked by aggression, self-injurious behavior, and severe tantrums. While treatment of interfering behavior has progressed in our field, there remain several areas of unmet medical need including most prominently a lack of any approved drug therapies for the core, defining symptoms of autism. We outline the progress to date in the field of autism drug treatment while taking a future look forward into how decades of work can inform better future steps in this field.

摘要

近几十年来,自闭症谱系障碍(ASD)的药物治疗研究掀起了一波浪潮。这项工作提高了我们治疗 ASD 常见行为挑战的能力,包括最突出的烦躁、攻击性、自伤行为和严重发脾气。虽然我们领域中干扰行为的治疗已经取得了进展,但仍有几个未满足的医疗需求领域,包括最突出的是缺乏任何批准的药物治疗自闭症的核心症状。我们概述了自闭症药物治疗领域迄今为止的进展,同时展望未来几十年的工作如何为该领域的未来步骤提供更好的信息。

相似文献

[1]
Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder.

J Autism Dev Disord. 2021-12

[2]
Psychopharmacology Management in Autism Spectrum Disorder.

Pediatr Clin North Am. 2024-4

[3]
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.

Autism. 2014-2-26

[4]
Aripiprazole for treating irritability associated with autism spectrum disorders.

Expert Opin Pharmacother. 2019-6-10

[5]
The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for core symptoms of autism spectrum disorder in adults.

Psychiatry Res. 2020-2-27

[6]
Psychopharmacologic management of serious behavioral disturbance in ASD.

Child Adolesc Psychiatr Clin N Am. 2014-1

[7]
Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.

Eur Psychiatry. 2016-1-21

[8]
Lurasidone for the treatment of irritability and anger in autism spectrum disorders.

Expert Opin Investig Drugs. 2017-8

[9]
Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents.

Paediatr Drugs. 2020-10

[10]
Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder.

Curr Psychiatry Rep. 2021-10-13

引用本文的文献

[1]
Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders.

Nutrients. 2025-4-15

[2]
Virtual environments as a novel and promising approach in (neuro)diagnosis and (neuro)therapy: a perspective on the example of autism spectrum disorder.

Front Neurosci. 2025-1-15

[3]
Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial.

JMIR Res Protoc. 2025-1-30

[4]
Electroconvulsive therapy in autism spectrum disorders: an update to the literature.

Curr Opin Psychiatry. 2025-3-1

[5]
Discordance Between Psychiatric Diagnoses and Medication Use in Children and Adults With Autism Presenting in Crisis.

Focus (Am Psychiatr Publ). 2024-4

[6]
Autism Across the Lifespan.

Focus (Am Psychiatr Publ). 2024-4

[7]
Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid.

J Autism Dev Disord. 2025-1

[8]
Current and future directions of drug delivery for the treatment of mental illnesses.

Adv Drug Deliv Rev. 2023-6

[9]
Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder.

Sci Rep. 2023-3-30

[10]
Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis.

J Autism Dev Disord. 2024-3

本文引用的文献

[1]
Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial.

J Am Acad Child Adolesc Psychiatry. 2021-7

[2]
Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents.

Paediatr Drugs. 2020-10

[3]
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study.

J Autism Dev Disord. 2021-4

[4]
Symptom scores and medication treatment patterns in children with ADHD versus autism.

Psychiatry Res. 2020-4-9

[5]
Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.

Transl Psychiatry. 2020-1-27

[6]
Emerging biomarkers in autism spectrum disorder: a systematic review.

Ann Transl Med. 2019-12

[7]
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder.

J Am Acad Child Adolesc Psychiatry. 2021-2

[8]
Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.

Mol Autism. 2020-1-15

[9]
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder.

J Med Chem. 2020-1-17

[10]
Effects of CBD-Enriched Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use.

Front Neurol. 2019-10-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索